Pia Österlund

10.9k total citations · 3 hit papers
96 papers, 4.2k citations indexed

About

Pia Österlund is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Pia Österlund has authored 96 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 14 papers in Hepatology. Recurrent topics in Pia Österlund's work include Colorectal Cancer Treatments and Studies (44 papers), Gastric Cancer Management and Outcomes (16 papers) and Cancer Treatment and Pharmacology (15 papers). Pia Österlund is often cited by papers focused on Colorectal Cancer Treatments and Studies (44 papers), Gastric Cancer Management and Outcomes (16 papers) and Cancer Treatment and Pharmacology (15 papers). Pia Österlund collaborates with scholars based in Finland, Sweden and Denmark. Pia Österlund's co-authors include Dirk Arnold, Leena‐Maija Soveri, Julien Taı̈eb, Thierry de Baère, Andrés Cervantes, Takayuki Yoshino, Jenny F. Seligmann, Susana Roselló, Nicola Normanno and Erika Martinelli and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Pia Österlund

90 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

2012 829 citations Dirk Arnold, Pia Österlund et al. profile →
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2022 774 citations Andrés Cervantes, R. Adam et al. Annals of Oncology profile →
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

2012 714 citations Halfdan Sørbye, Staffan Welin et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pia Österlund Finland	27	3.0k	1.0k	961	787	626	96	4.2k
David R. Fogelman United States	36	3.4k 1.1×	944 0.9×	815 0.8×	663 0.8×	497 0.8×	143	4.3k
Thomas Aparicio France	40	3.6k 1.2×	2.1k 2.0×	1.5k 1.5×	716 0.9×	370 0.6×	254	6.5k
Benjamin Tan United States	33	2.9k 1.0×	1.9k 1.9×	434 0.5×	829 1.1×	543 0.9×	163	5.0k
Giuseppe Colucci Italy	27	2.0k 0.7×	1.1k 1.1×	503 0.5×	615 0.8×	428 0.7×	123	3.7k
Daneng Li United States	24	1.8k 0.6×	690 0.7×	685 0.7×	286 0.4×	1.1k 1.8×	136	3.5k
Chun‐Nan Yeh Taiwan	41	1.7k 0.6×	2.2k 2.1×	676 0.7×	880 1.1×	727 1.2×	280	5.5k
T.R. Jeffry Evans United Kingdom	29	1.3k 0.4×	591 0.6×	488 0.5×	859 1.1×	489 0.8×	108	3.7k
Ralph Levitt United States	27	2.1k 0.7×	892 0.9×	424 0.4×	670 0.9×	479 0.8×	67	3.6k
David J. Pinato United Kingdom	38	3.0k 1.0×	1.3k 1.2×	1.4k 1.5×	1.3k 1.6×	2.2k 3.5×	233	6.3k
Florencia G. Que United States	42	3.3k 1.1×	1.5k 1.5×	2.1k 2.1×	381 0.5×	909 1.5×	105	5.5k

Countries citing papers authored by Pia Österlund

Since Specialization

Citations

This map shows the geographic impact of Pia Österlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Österlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Österlund more than expected).

Fields of papers citing papers by Pia Österlund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Österlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Österlund. The network helps show where Pia Österlund may publish in the future.

Co-authorship network of co-authors of Pia Österlund

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Österlund. A scholar is included among the top collaborators of Pia Österlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Österlund. Pia Österlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tolonen, Antti, et al.. (2023). Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer. Cancers. 15(13). 3398–3398. 3 indexed citations

Österlund, Pia, Emerik Österlund, Päivi Halonen, et al.. (2023). 607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy). Annals of Oncology. 34. S436–S437. 1 indexed citations

Punt, Cornelis J.A., Volker Heinemann, Tim Maughan, et al.. (2023). Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer. ESMO Open. 8(2). 101199–101199. 4 indexed citations

Tuokkola, Jetta, et al.. (2023). Time to act! - A cross-sectional study on how nutritional risk increases during hospitalization and associates with worse outcome. Clinical Nutrition ESPEN. 57. 364–374. 3 indexed citations

Liposits, Gábor, Halla Skúladóttir, Jesper Ryg, et al.. (2022). The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine. 11(19). 5603–5603. 11 indexed citations

Karimi, Masoud, Pia Österlund, Klara Hammarström, et al.. (2022). Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters. Cancers. 14(24). 6238–6238. 3 indexed citations

Cervantes, Andrés, R. Adam, Susana Roselló, et al.. (2022). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 34(1). 10–32. 774 indexed citations breakdown →

Horgan, Denis, Anne‐Marie Baird, Mark R. Middleton, et al.. (2022). How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?. Healthcare. 10(9). 1618–1618. 4 indexed citations

Österlund, Pia, et al.. (2022). GLIM in diagnosing malnutrition and predicting outcome in ambulatory patients with head and neck cancer. Frontiers in Nutrition. 9. 1030619–1030619. 14 indexed citations

10.

Langer, Seppo W., Birgitte Federspiel, Geir Olav Hjortland, et al.. (2020). PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3. PLoS ONE. 15(12). e0243900–e0243900. 14 indexed citations

11.

Peltonen, Reetta, et al.. (2020). Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. PLoS ONE. 15(8). e0236569–e0236569. 16 indexed citations

12.

Österlund, Pia, Päivi Halonen, Tapio Salminen, et al.. (2020). SO-18 Single-arm multicentre phase II study of bevacizumab (B) combined with 9-weekly alternating CAPOX and CAPIRI as first-line treatment of patients with metastatic colorectal cancer (mCRC): Main results of the AXOAXI-trial. Annals of Oncology. 31. S223–S223. 1 indexed citations

13.

Grönberg, Malin, Seppo W. Langer, Morten Ladekarl, et al.. (2018). Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Medical Oncology. 35(4). 47–47. 10 indexed citations

14.

Forsgård, Richard A., Vannina G. Marrachelli, Katri Korpela, et al.. (2017). Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats. Cancer Chemotherapy and Pharmacology. 80(2). 317–332. 63 indexed citations

15.

Grönberg, Malin, Birgitte Federspiel, Jean‐Yves Scoazec, et al.. (2017). Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLoS ONE. 12(11). e0187667–e0187667. 27 indexed citations

16.

Guren, Tormod Kyrre, Elin H. Kure, Halfdan Sørbye, et al.. (2017). Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study. British Journal of Cancer. 116(10). 1271–1278. 51 indexed citations

17.

Loupakis, Fotios, Alexander Stein, Marc Ychou, et al.. (2015). A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer. Targeted Oncology. 11(3). 293–308. 22 indexed citations

18.

Ålgars, Annika, Pia Österlund, Minnamaija Lintunen, et al.. (2014). Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy. PLoS ONE. 9(6). e99590–e99590. 17 indexed citations

19.

Sørbye, Halfdan, Staffan Welin, Seppo W. Langer, et al.. (2013). Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas. 42(2). 382–382. 2 indexed citations

20.

Holma, Reetta, et al.. (2011). Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon. International Journal of Colorectal Disease. 27(2). 171–178. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact